Alignment Healthcare Statistics
Total Valuation
ALHC has a market cap or net worth of $983.79 million. The enterprise value is $835.76 million.
| Market Cap | 983.79M |
| Enterprise Value | 835.76M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALHC has 190.66 million shares outstanding. The number of shares has increased by 2.76% in one year.
| Shares Outstanding | 190.66M |
| Shares Change (YoY) | +2.76% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 6.90% |
| Owned by Institutions (%) | 84.78% |
| Float | 100.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| Forward PS | 0.40 |
| PB Ratio | 6.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.09.
| Current Ratio | 1.84 |
| Quick Ratio | 1.67 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.97 |
Financial Efficiency
Return on equity (ROE) is -76.10% and return on invested capital (ROIC) is -38.74%.
| Return on Equity (ROE) | -76.10% |
| Return on Assets (ROA) | -20.40% |
| Return on Capital (ROIC) | -38.74% |
| Revenue Per Employee | $1.19M |
| Profits Per Employee | -$96,365 |
| Employee Count | 1,536 |
| Asset Turnover | 2.51 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -22,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.97% in the last 52 weeks. The beta is 1.30, so ALHC's price volatility has been higher than the market average.
| Beta (1Y) | 1.30 |
| 52-Week Price Change | -4.97% |
| 50-Day Moving Average | 5.28 |
| 200-Day Moving Average | 6.45 |
| Relative Strength Index (RSI) | 53.76 |
| Average Volume (30 Days) | 921,174 |
Short Selling Information
The latest short interest is 4.69 million, so 2.46% of the outstanding shares have been sold short.
| Short Interest | 4.69M |
| Short Previous Month | 3.94M |
| Short % of Shares Out | 2.46% |
| Short % of Float | 4.68% |
| Short Ratio (days to cover) | 5.32 |
Income Statement
In the last 12 months, ALHC had revenue of $1.82 billion and -$148.02 million in losses. Loss per share was -$0.79.
| Revenue | 1.82B |
| Gross Profit | 201.03M |
| Operating Income | -126.96M |
| Pretax Income | -148.04M |
| Net Income | -148.02M |
| EBITDA | -102.82M |
| EBIT | -126.81M |
| Loss Per Share | -$0.79 |
Balance Sheet
The company has $318.82 million in cash and $170.79 million in debt, giving a net cash position of $148.03 million or $0.78 per share.
| Cash & Cash Equivalents | 318.82M |
| Total Debt | 170.79M |
| Net Cash | 148.03M |
| Net Cash Per Share | $0.78 |
| Equity / Book Value | 156.95M |
| Book Value Per Share | 0.82 |
| Working Capital | 220.52M |
Cash Flow
In the last 12 months, operating cash flow was -$59.19 million and capital expenditures -$36.00 million, giving a free cash flow of -$95.18 million.
| Operating Cash Flow | -59.19M |
| Capital Expenditures | -36.00M |
| Free Cash Flow | -95.18M |
| FCF Per Share | -$0.51 |
Margins
Gross margin is 11.02%, with operating and profit margins of -6.96% and -8.12%.
| Gross Margin | 11.02% |
| Operating Margin | -6.96% |
| Pretax Margin | -8.12% |
| Profit Margin | -8.12% |
| EBITDA Margin | -5.64% |
| EBIT Margin | -6.95% |
| FCF Margin | -5.22% |
Dividends & Yields
ALHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.76% |
| Shareholder Yield | -2.76% |
| Earnings Yield | -15.05% |
| FCF Yield | -9.68% |
Analyst Forecast
The average price target for ALHC is $8.86, which is 71.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.86 |
| Price Target Difference | 71.71% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 9.78% |
| EPS Growth Forecast (5Y) | -29.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALHC has an Altman Z-Score of 2.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 2 |